Pages that link to "Item:Q1682981"
From MaRDI portal
The following pages link to Optimization of combined leukemia therapy by finite-dimensional optimal control modeling (Q1682981):
Displaying 13 items.
- Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia (Q1719795) (← links)
- Optimization of combination therapy for chronic myeloid leukemia with dosing constraints (Q1789085) (← links)
- Mathematical modeling of cyclic treatments of chronic myeloid leukemia (Q1942444) (← links)
- On optimal and suboptimal treatment strategies for a mathematical model of leukemia (Q1942615) (← links)
- A quantitative study on the role of TKI combined with Wnt/\(\beta\)-catenin signaling and IFN-\(\alpha\) in the treatment of CML through deterministic and stochastic approaches (Q2120382) (← links)
- Optimal control analysis of a leukemia model under imatinib treatment (Q2228752) (← links)
- An analysis of strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia with imatinib-resistant mutations (Q2344606) (← links)
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia (Q2472884) (← links)
- An optimal strategy for leukemia therapy: a multi-objective approach (Q2891082) (← links)
- Optimal therapy protocols in the mathematical model of acute leukemia with several phase constraints (Q2931071) (← links)
- STABILITY ANALYSIS OF A MATHEMATICAL MODEL FOR CHRONIC MYELOID LEUKEMIA ERADICATION (Q5003137) (← links)
- Progression, detection and remission: evolution of chronic myeloid leukemia using a three-stage probabilistic model (Q6138303) (← links)
- Two numerical methods for solving a nonlinear system of integral equations of mixed Volterra-Fredholm type arising from a control problem related to leukemia (Q6612478) (← links)
